@article{TCR29228,
author = {Camille Travert and Pascale Tomasini and Arnaud Jeanson and Laurent Greillier and Fabrice Barlesi},
title = {First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer},
journal = {Translational Cancer Research},
volume = {8},
number = {7},
year = {2019},
keywords = {},
abstract = {In these past few years, immune checkpoint inhibitors (ICI) in locally advanced or metastatic non-small cell lung cancer (NSCLC) have fundamentally changed the prognosis for some patients.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/29228}
}